Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When you inject semaglutide weekly, the same injection site used repeatedly can develop a condition called lipohypertrophy—a thickening and hardening of fatty tissue beneath the skin. PlexusDx specializes in compounded semaglutide therapy and emphasizes proper injection technique, including strategic site rotation, to help patients achieve safe, sustained results.

What Happens When You Repeat Injection Sites

Injecting semaglutide into the same spot week after week triggers an inflammatory response in the subcutaneous tissue. Your body recognizes repeated needle trauma and responds by accumulating extra fat cells and collagen, creating a raised, firm bump under your skin. This process, called lipohypertrophy, is not dangerous by itself, but it interferes with how your medication enters your bloodstream.

When lipohypertrophy develops, the thickened tissue absorbs medication unevenly and more slowly than healthy skin does. This means your weekly dose may not deliver the expected therapeutic effect, leading to inconsistent blood sugar control and reduced weight loss efficacy. Studies show that patients who do not rotate sites experience larger variations in medication absorption rates between doses.

How Site Rotation Improves Medication Absorption

Rotating your injection sites across different areas of the body ensures that each location heals fully between doses. The abdomen, thighs, and upper arms all contain subcutaneous fat layers suitable for GLP-1 injection. By spacing injections at least one to two inches apart and moving between body regions, you allow inflamed tissue time to recover and return to normal thickness.

Healthy, uninjured skin provides predictable, consistent absorption of semaglutide. When medication enters uniform tissue without lipohypertrophy, the drug reaches your bloodstream at reliable rates each week. This consistency is especially important for patients being titrated to higher doses, as steady absorption prevents unexpected side effects and optimizes weight loss outcomes.

Recommended Site Rotation Pattern for Semaglutide

Healthcare providers typically recommend a four-site rotation system: lower abdomen, upper abdomen, left thigh, and right thigh. Some patients also include the upper outer arm, creating a six-site pattern for longer-term therapy. Within each region, move your injection at least one inch to either side from the previous week's location to avoid repeatedly puncturing the same area.

Document each injection in a journal or phone note to track which site you used last week. This simple habit prevents accidental repeats and ensures you genuinely rotate between locations. If you notice any persistent lumps, redness, or hardness at any site, skip that area for at least two weeks and allow the tissue to recover while using other regions.

Why PlexusDx Patients Should Practice Proper Injection Technique

PlexusDx provides compounded semaglutide injections starting at $149 per month, delivered to all 50 states without insurance requirements. When you invest in personalized GLP-1 therapy, maximizing medication effectiveness through correct injection practices ensures you see the weight loss and metabolic benefits you expect. Proper site rotation is a free, evidence-based step that directly enhances your treatment outcomes.

PlexusDx patients can further optimize their therapy by adding the Precision Peptide Genetic Test ($99 after the first month of treatment), which identifies genetic variations affecting GLP-1 receptor sensitivity and peptide pathway efficiency. Understanding your genetic profile helps your provider adjust your semaglutide protocol for even better results, but this precision only works if your injection technique delivers consistent drug absorption—making site rotation essential.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can lipohypertrophy from repeated injections cause permanent damage?

Lipohypertrophy is typically reversible if you stop injecting into that site and allow several weeks for the tissue to heal. However, very severe cases may take months to fully resolve. Rotating sites from the beginning of your semaglutide therapy prevents this problem entirely.

How many different injection sites do I really need?

A minimum of four rotating sites (lower abdomen, upper abdomen, left thigh, right thigh) is effective for most patients on weekly GLP-1 injections. If you plan to use semaglutide long-term, a six-site pattern including both upper arms provides even greater tissue recovery time between injections.

Does PlexusDx provide injection training or site rotation guidance?

PlexusDx delivers compounded semaglutide injections starting at $149 per month and includes access to clinical support. When you start therapy, our team provides clear instructions on proper injection technique, including site rotation recommendations tailored to your treatment plan.

What should I do if I already have lipohypertrophy from previous injections?

Stop injecting into that area immediately and switch to a different site. Most lipohypertrophy resolves within 2–4 weeks once you discontinue needle trauma to the region. If hardness persists beyond four weeks, contact your healthcare provider to rule out infection or other complications.

Can the Precision Peptide Genetic Test help predict injection site problems?

The PlexusDx Precision Peptide Genetic Test identifies genetic variants in GLP-1 receptor pathways and metabolic genes, helping optimize your dose and compound selection—but it does not predict lipohypertrophy risk. However, proper site rotation benefits all patients regardless of genetic profile and ensures your personalized therapy delivers reliable medication absorption.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves